Indications for portal pressure measurement in chronic liver disease

References

• de FR, Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis 2001;5:645–63.
   PubMedGoogle Scholar
• Bendtsen F, Krag A, Moller S. Treatment of acute variceal bleeding. Dig Liver Dis 2008;40:328–36.
   PubMedGoogle Scholar
• Moller S, Henriksen JH. Cardiovascular complications of cirrhosis. Gut 2008;57:268–78.
   PubMed Web of Science ®Google Scholar
• Moller S, Henriksen JH, Bendtsen F. Ascites: pathogenesis and therapeutic principles. Scand J Gastroenterol 2009;44:902–11.
   PubMed Web of Science ®Google Scholar
• Cardenas A, Gines P. Portal hypertension. Curr Opin Gastroenterol 2009;25:195–201.
   PubMed Web of Science ®Google Scholar
• Feu F, Garcia-Pagan JC, Bosch J, Luca A, Teres J, Escorsell A, Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 1995;346:1056–9.
   PubMed Web of Science ®Google Scholar
• Merkel C, Bolognesi M, Sacerdoti D, Bombonato G, Bellini B, Bighin R, The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 2000;32:930–4.
   PubMed Web of Science ®Google Scholar
• Bureau C, Peron JM, Alric L, Morales J, Sanchez J, Barange K, “A La Carte” treatment of portal hypertension: Adapting medical therapy to hemodynamic response for the prevention of bleeding. Hepatology 2002;36:1361–6.
   PubMed Web of Science ®Google Scholar
• Abraldes JG, Tarantino I, Turnes J, Garcia-Pagan JC, Rodes J, Bosch J. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology 2003;37:902–8.
   PubMed Web of Science ®Google Scholar
• Groszmann RJ, Wongcharatrawee S. The hepatic venous pressure gradient: anything worth doing should be done right. Hepatology 2004;39:280–2.
   PubMed Web of Science ®Google Scholar
• Thalheimer U, Leandro G, Samonakis DN, Triantos CK, Patch D, Burroughs AK. Assessment of the agreement between wedge hepatic vein pressure and portal vein pressure in cirrhotic patients. Dig Liver Dis 2005;37:601–8.
   PubMedGoogle Scholar
• Zipprich A, Winkler M, Seufferlein T, Dollinger MM. Comparison of balloon vs. straight catheter for the measurement of portal hypertension. Aliment Pharmacol Ther 2010;32:1351–6.
   PubMedGoogle Scholar
• Keiding S, Vilstrup H. Intrahepatic heterogeneity of hepatic venous pressure gradient in human cirrhosis. Scand J Gastroenterol 2002;37:960–4.
   PubMed Web of Science ®Google Scholar
• Bosch J, Garcia-Pagan JC, Berzigotti A, Abraldes JG. Measurement of portal pressure and its role in the management of chronic liver disease. Semin Liver Dis 2006;26:348–62.
   PubMed Web of Science ®Google Scholar
• Moitinho E, Escorsell A, Bandi JC, Salmeron JM, Garcia-Pagan JC, Rodes J, Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 1999;117:626–31.
   PubMed Web of Science ®Google Scholar
• D'Amico G, Garcia-Pagan JC, Luca A, Bosch J. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. 1. Gastroenterology 2006;131:1611–24.
   PubMed Web of Science ®Google Scholar
• Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 2007;133:481–8.
   PubMed Web of Science ®Google Scholar
• Ripoll C, Groszmann RJ, Garcia-Tsao G, Bosch J, Grace N, Burroughs A, Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis. J Hepatol 2009;50:923–8.
   PubMed Web of Science ®Google Scholar
• Kim MY, Baik SK, Yea CJ, Lee IY, Kim HJ, Park KW, Hepatic venous pressure gradient can predict the development of hepatocellular carcinoma and hyponatremia in decompensated alcoholic cirrhosis. Eur J Gastroenterol Hepatol 2009;21:1241–6.
   PubMed Web of Science ®Google Scholar
• Hobolth L, Krag A, Bendtsen F. The recent reduction in mortality from bleeding oesophageal varices is primarily observed from days 1 to 5. Liver Int 2010;30:455–62.
   PubMed Web of Science ®Google Scholar
• Burroughs AK, Triantos CK, O'Beirne J, Patch D. Predictors of early rebleeding and mortality after acute variceal hemorrhage in patients with cirrhosis. Nat Clin Pract Gastroenterol Hepatol 2009;6:72–3.
   PubMedGoogle Scholar
• Bendtsen F, Simonsen L, Henriksen JH. Effect on hemodynamics of a liquid meal alone and in combination with propranolol in cirrhosis. Gastroenterology 1992;102:1017–23.
   PubMedGoogle Scholar
• Garcia-Pagan JC, De GA, Bosch J. Review article: the modern management of portal hypertension–primary and secondary prophylaxis of variceal bleeding in cirrhotic patients. Aliment Pharmacol Ther 2008;28:178–86.
   PubMed Web of Science ®Google Scholar
• Bendtsen F, Henriksen JH, Sorensen TI. Propranolol and haemodynamic response in cirrhosis. J Hepatol 1991;13:144–8.
   PubMed Web of Science ®Google Scholar
• Klein CP, Kalk JF, Muting D, Klein CG. The effect of alcohol on portal vein hemodynamics in nutritional-toxic liver cirrhosis. Dtsch Med Wochenschr 1993;118:89–93.
   PubMedGoogle Scholar
• Villanueva C, Aracil C, Colomo A, Hernandez-Gea V, Lopez-Balaguer JM, varez-Urturi C, Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding. Gastroenterology 2009;137:119–28.
   PubMed Web of Science ®Google Scholar
• La Mura V, Abraldes JG, Raffa S, Retto O, Berzigotti A, Garcia-Pagan JC, Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension. J Hepatol 2009;51:279–87.
   PubMedGoogle Scholar
• de FR. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010;53:762–8.
   PubMedGoogle Scholar
• Thalheimer U, Bellis L, Puoti C, Burroughs AK. Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as a guide for prophylaxis and therapy of bleeding and rebleeding? No. Eur J Intern Med 2011;22:5–7.
   PubMedGoogle Scholar
• Reiberger T, Rutter K, Ferlitsch A, Payer BA, Hofer H, Beinhardt S, Portal pressure predicts outcome and safety of antiviral therapy in cirrhotic patients with hepatitis C virus infection. Clin Gastroenterol Hepatol 2011;9:602–8.
   PubMed Web of Science ®Google Scholar